Eric Lefkofsky is one of the most prominent of innovators and entrepreneurs coming out of Chicago. Lefkofsky has worked in the tech field with a specialty in data aggregation for decades and now he is pushing those skills toward an important area of health care: cancer care and cancer research. Eric Lefkofsky is the man behind the newest company grabbing headlines in the healthcare field and his work with that company, Tempus, will be something that could fundamentally shift how health care providers approach cancer care.
Knowing that cancer care can be improved upon was almost the only impetus that Eric Lefkofsky needed in order to push his unique skills toward developing technological solutions for the field. Cancer care is notoriously unreliable between different care clinics and even health professionals. The reason? Healthcare providers don’t have proper access to the kind of life changing research that is going on throughout the country. The advent of Electronic Health Records, or EHRs for short, was supposed to change how these facilities shared information but it just didn’t happen. That is where Tempus comes into play and more
Tempus reached a valuation of nearly $700 million in 2017 after starting the company back in 2016. Lefkofsky, the CEO of the company, knows that the value in his company exceeds dollars and cents and is instead valued in terms of lives saved. Lefkofsky points out it simply, “In oncology, and across healthcare more broadly, datasets have historically been small and disorganized.” Lefkofsky goes on to point out that technology is opening up the pathways to sharing information faster and more efficiently than ever — and that is exactly what Tempus will be doing.
Tempus is essentially an operating system overlay that goes atop the data that healthcare providers are already working with. Tempus takes in that data, sorts it, and puts it into a database that can be accessed by healthcare patients and providers. Patients and providers will then have access to more information at the click of a button than they ever had before, thus allowing them to focus and tailor their treatment plans and routines.